Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health
replication in a randomized design is needed before pentoxifylline can be recommended as a PD treatment
Recent research has shown that ferroptosis may contribute to the development of complications associated with diabetes mellitus, including kidney disease [8], osteoporosis [9], encephalopathy [10], cardiomyopathy [11], retinopathy [12], and MASLD [13, 14]
Many patients use this program alongside hormone therapy, mental health care, or IV nutrient support